Recombinant factor VIIa use in refractory ulcer bleeding in uremic patient

An Yi Wang, Ang Yuan, Chien Hua Huang, Wei Tien Chang, Po Chin Liang, Tzu Hsin Lin, Shyr Chyr Chen

研究成果: 雜誌貢獻文章同行評審

1 引文 斯高帕斯(Scopus)


Peptic ulcer bleeding is thought to be a major cause of bleeding in patients with end-stage renal disease and is more complicated in uremic patients. We described a 41-year-old man with end-stage renal disease who underwent hemodialysis with refractory ulcer bleeding, failure to all traditional peptic ulcer treatments, and correction of uremic component, who has been successfully treated by using recombinant factor VIIa. There have been few case reports in dealing refractory upper gastrointestinal bleeding in uremic patients in the literature; and in this case report, we demonstrates that recombinant factor VIIa could be used as a rescue therapy in these highsurgical risk patients when medical therapy fails.

頁(從 - 到)1319.e1-1319.e4
期刊American Journal of Emergency Medicine
出版狀態已發佈 - 1月 1 2012

ASJC Scopus subject areas

  • 急診醫學


深入研究「Recombinant factor VIIa use in refractory ulcer bleeding in uremic patient」主題。共同形成了獨特的指紋。